APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Corticosteroid

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ophthalmic Corticosteroid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025196 pages

Choose your research edition.

Industry ResearchOphthalmic Corticosteroid Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Corticosteroid Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Ophthalmic Corticosteroid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Corticosteroid Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Corticosteroid Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ophthalmic Corticosteroid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Ophthalmic Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ophthalmic Corticosteroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmic Corticosteroid include Novartis AG, Pfizer, GlaxoSmithKline, Bayer AG, Sun Pharmaceutical, Regeneron Pharmaceuticals, Orchidia, Innovative Pharmaceuticals and General Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Ophthalmic Corticosteroid market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmic Corticosteroid and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmic Corticosteroid revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Ophthalmic Corticosteroid market size, projected growth trends, production technologies, key applications, and end-use industries.

Ophthalmic Corticosteroid Segment by Company

Novartis AG

Pfizer

GlaxoSmithKline

Bayer AG

Sun Pharmaceutical

Regeneron Pharmaceuticals

Orchidia

Innovative Pharmaceuticals

General Pharmaceuticals

Genentech

Bausch Health

Bausch and Lomb

Allergan

Alimera Sciences

Ajanta Pharma

Ophthalmic Corticosteroid Segment by Type

Dexamethasone

Difluprednate

Fluorometholone

Loteprednol

Others

Ophthalmic Corticosteroid Segment by Application

Hospital Pharmacies

Research Institute

Online Pharmacies

Retail Pharmacies

Others

Ophthalmic Corticosteroid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Corticosteroid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Corticosteroid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Corticosteroid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Ophthalmic Corticosteroid in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ophthalmic Corticosteroid industry.

Chapter 3: Detailed analysis of Ophthalmic Corticosteroid companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ophthalmic Corticosteroidrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ophthalmic Corticosteroid Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Dexamethasone Table 3. Key Players of Difluprednate Table 4. Key Players of Fluorometholone Table 3. Key Players of Loteprednol Table 4. Key Players of Others Table 5. Global Ophthalmic Corticosteroid Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Pharmacies Table 7. Key Players of Research Institute Table 8. Key Players of Online Pharmacies Table 9. Key Players of Retail Pharmacies Table 10. Key Players of Others Table 11. Global Ophthalmic Corticosteroid Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Ophthalmic Corticosteroid Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Ophthalmic Corticosteroid Market Share by Region (2021-2026) Table 14. Global Ophthalmic Corticosteroid Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Ophthalmic Corticosteroid Market Share by Region (2027-2032) Table 16. Ophthalmic Corticosteroid Industry Trends Table 17. Ophthalmic Corticosteroid Industry Drivers Table 18. Ophthalmic Corticosteroid Industry Opportunities and Challenges Table 19. Ophthalmic Corticosteroid Industry Restraints Table 20. Global Ophthalmic Corticosteroid Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Ophthalmic Corticosteroid Revenue Market Share by Company (2021-2026) Table 22. Global Ophthalmic Corticosteroid Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Ophthalmic Corticosteroid Key Company Head Office and Area Served Table 24. Global Ophthalmic Corticosteroid Company, Product Type & Application Table 25. Global Ophthalmic Corticosteroid Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Ophthalmic Corticosteroid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Ophthalmic Corticosteroid Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Ophthalmic Corticosteroid Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Ophthalmic Corticosteroid Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Ophthalmic Corticosteroid Revenue Market Share by Type (2021-2026) Table 32. Global Ophthalmic Corticosteroid Revenue Market Share by Type (2027-2032) Table 33. Global Ophthalmic Corticosteroid Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Ophthalmic Corticosteroid Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Ophthalmic Corticosteroid Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Ophthalmic Corticosteroid Revenue Market Share by Application (2021-2026) Table 37. Global Ophthalmic Corticosteroid Revenue Market Share by Application (2027-2032) Table 38. Novartis AG Company Information Table 39. Novartis AG Business Overview Table 40. Novartis AG Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Novartis AG Ophthalmic Corticosteroid Product Portfolio Table 42. Novartis AG Recent Development Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Pfizer Ophthalmic Corticosteroid Product Portfolio Table 47. Pfizer Recent Development Table 48. GlaxoSmithKline Company Information Table 49. GlaxoSmithKline Business Overview Table 50. GlaxoSmithKline Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. GlaxoSmithKline Ophthalmic Corticosteroid Product Portfolio Table 52. GlaxoSmithKline Recent Development Table 53. Bayer AG Company Information Table 54. Bayer AG Business Overview Table 55. Bayer AG Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Bayer AG Ophthalmic Corticosteroid Product Portfolio Table 57. Bayer AG Recent Development Table 58. Sun Pharmaceutical Company Information Table 59. Sun Pharmaceutical Business Overview Table 60. Sun Pharmaceutical Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Sun Pharmaceutical Ophthalmic Corticosteroid Product Portfolio Table 62. Sun Pharmaceutical Recent Development Table 63. Regeneron Pharmaceuticals Company Information Table 64. Regeneron Pharmaceuticals Business Overview Table 65. Regeneron Pharmaceuticals Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Regeneron Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio Table 67. Regeneron Pharmaceuticals Recent Development Table 68. Orchidia Company Information Table 69. Orchidia Business Overview Table 70. Orchidia Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Orchidia Ophthalmic Corticosteroid Product Portfolio Table 72. Orchidia Recent Development Table 73. Innovative Pharmaceuticals Company Information Table 74. Innovative Pharmaceuticals Business Overview Table 75. Innovative Pharmaceuticals Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Innovative Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio Table 77. Innovative Pharmaceuticals Recent Development Table 78. General Pharmaceuticals Company Information Table 79. General Pharmaceuticals Business Overview Table 80. General Pharmaceuticals Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. General Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio Table 82. General Pharmaceuticals Recent Development Table 83. Genentech Company Information Table 84. Genentech Business Overview Table 85. Genentech Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Genentech Ophthalmic Corticosteroid Product Portfolio Table 87. Genentech Recent Development Table 88. Bausch Health Company Information Table 89. Bausch Health Business Overview Table 90. Bausch Health Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Bausch Health Ophthalmic Corticosteroid Product Portfolio Table 92. Bausch Health Recent Development Table 93. Bausch and Lomb Company Information Table 94. Bausch and Lomb Business Overview Table 95. Bausch and Lomb Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Bausch and Lomb Ophthalmic Corticosteroid Product Portfolio Table 97. Bausch and Lomb Recent Development Table 98. Allergan Company Information Table 99. Allergan Business Overview Table 100. Allergan Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Allergan Ophthalmic Corticosteroid Product Portfolio Table 102. Allergan Recent Development Table 103. Alimera Sciences Company Information Table 104. Alimera Sciences Business Overview Table 105. Alimera Sciences Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. Alimera Sciences Ophthalmic Corticosteroid Product Portfolio Table 107. Alimera Sciences Recent Development Table 108. Ajanta Pharma Company Information Table 109. Ajanta Pharma Business Overview Table 110. Ajanta Pharma Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. Ajanta Pharma Ophthalmic Corticosteroid Product Portfolio Table 112. Ajanta Pharma Recent Development Table 113. North America Ophthalmic Corticosteroid Market Size by Type (2021-2026) & (US$ Million) Table 114. North America Ophthalmic Corticosteroid Market Size by Type (2027-2032) & (US$ Million) Table 115. North America Ophthalmic Corticosteroid Market Size by Application (2021-2026) & (US$ Million) Table 116. North America Ophthalmic Corticosteroid Market Size by Application (2027-2032) & (US$ Million) Table 117. North America Ophthalmic Corticosteroid Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Ophthalmic Corticosteroid Market Size by Country (2021-2026) Table 119. North America Ophthalmic Corticosteroid Market Size by Country (2027-2032) Table 120. Europe Ophthalmic Corticosteroid Market Size by Type (2021-2026) & (US$ Million) Table 121. Europe Ophthalmic Corticosteroid Market Size by Type (2027-2032) & (US$ Million) Table 122. Europe Ophthalmic Corticosteroid Market Size by Application (2021-2026) & (US$ Million) Table 123. Europe Ophthalmic Corticosteroid Market Size by Application (2027-2032) & (US$ Million) Table 124. Europe Ophthalmic Corticosteroid Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Ophthalmic Corticosteroid Market Size by Country (2021-2026) Table 126. Europe Ophthalmic Corticosteroid Market Size by Country (2027-2032) Table 127. China Ophthalmic Corticosteroid Market Size by Type (2021-2026) & (US$ Million) Table 128. China Ophthalmic Corticosteroid Market Size by Type (2027-2032) & (US$ Million) Table 129. China Ophthalmic Corticosteroid Market Size by Application (2021-2026) & (US$ Million) Table 130. China Ophthalmic Corticosteroid Market Size by Application (2027-2032) & (US$ Million) Table 131. Asia Ophthalmic Corticosteroid Market Size by Type (2021-2026) & (US$ Million) Table 132. Asia Ophthalmic Corticosteroid Market Size by Type (2027-2032) & (US$ Million) Table 133. Asia Ophthalmic Corticosteroid Market Size by Application (2021-2026) & (US$ Million) Table 134. Asia Ophthalmic Corticosteroid Market Size by Application (2027-2032) & (US$ Million) Table 135. Asia Ophthalmic Corticosteroid Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Asia Ophthalmic Corticosteroid Market Size by Country (2021-2026) Table 137. Asia Ophthalmic Corticosteroid Market Size by Country (2027-2032) Table 138. South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Type (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Type (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Application (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Application (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2021-2026) Table 144. South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2027-2032) Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Ophthalmic Corticosteroid Product Image Figure 2. Global Ophthalmic Corticosteroid Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Ophthalmic Corticosteroid Market Share by Type: 2025 VS 2032 Figure 4. Dexamethasone Image Figure 5. Difluprednate Image Figure 6. Fluorometholone Image Figure 7. Loteprednol Image Figure 8. Others Image Figure 9. Global Ophthalmic Corticosteroid Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Ophthalmic Corticosteroid Market Share by Application: 2025 VS 2032 Figure 11. Hospital Pharmacies Image Figure 12. Research Institute Image Figure 13. Online Pharmacies Image Figure 14. Retail Pharmacies Image Figure 15. Others Image Figure 16. Global Ophthalmic Corticosteroid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 18. Global Ophthalmic Corticosteroid Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Ophthalmic Corticosteroid Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Ophthalmic Corticosteroid Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Ophthalmic Corticosteroid Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Ophthalmic Corticosteroid Revenue Market Share by Type (2021-2032) Figure 25. Global Ophthalmic Corticosteroid Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Ophthalmic Corticosteroid Revenue Market Share by Application (2021-2032) Figure 27. North America Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 28. North America Ophthalmic Corticosteroid Market Share by Type (2021-2032) Figure 29. North America Ophthalmic Corticosteroid Market Share by Application (2021-2032) Figure 30. North America Ophthalmic Corticosteroid Market Share by Country (2021-2032) Figure 31. United States Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 32. Canada Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 34. Europe Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 35. Europe Ophthalmic Corticosteroid Market Share by Type (2021-2032) Figure 36. Europe Ophthalmic Corticosteroid Market Share by Application (2021-2032) Figure 37. Europe Ophthalmic Corticosteroid Market Share by Country (2021-2032) Figure 38. Germany Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 39. France Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 41. Italy Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 42. Russia Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 44. China Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 45. China Ophthalmic Corticosteroid Market Share by Type (2021-2032) Figure 46. China Ophthalmic Corticosteroid Market Share by Application (2021-2032) Figure 47. Asia Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 48. Asia Ophthalmic Corticosteroid Market Share by Type (2021-2032) Figure 49. Asia Ophthalmic Corticosteroid Market Share by Application (2021-2032) Figure 50. Asia Ophthalmic Corticosteroid Market Share by Country (2021-2032) Figure 51. Japan Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 55. India Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 56. Australia Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Ophthalmic Corticosteroid Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Ophthalmic Corticosteroid Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Ophthalmic Corticosteroid Market Share by Country (2021-2032) Figure 61. Brazil Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 66. UAE Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 68. Chile Ophthalmic Corticosteroid Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Dexamethasone
  • Difluprednate
  • Fluorometholone
  • Loteprednol
  • Others
Applications
  • Hospital Pharmacies
  • Research Institute
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Novartis AG
  • Pfizer
  • GlaxoSmithKline
  • Bayer AG
  • Sun Pharmaceutical
  • Regeneron Pharmaceuticals
  • Orchidia
  • Innovative Pharmaceuticals
  • General Pharmaceuticals
  • Genentech
  • Bausch Health
  • Bausch and Lomb
  • Allergan
  • Alimera Sciences
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Ophthalmic Corticosteroid Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Dexamethasone
  5. 1.2.3 Difluprednate
  6. 1.2.4 Fluorometholone
  7. 1.2.5 Loteprednol
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Ophthalmic Corticosteroid Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital Pharmacies
  12. 1.3.3 Research Institute
  13. 1.3.4 Online Pharmacies
  14. 1.3.5 Retail Pharmacies
  15. 1.3.6 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Ophthalmic Corticosteroid Growth Trends by Region
  18. 1.5.1 Global Ophthalmic Corticosteroid Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Ophthalmic Corticosteroid Market Size by Region (2021-2026)
  20. 1.5.3 Ophthalmic Corticosteroid Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Ophthalmic Corticosteroid Market Dynamics
  1. 2.1 Ophthalmic Corticosteroid Industry Trends
  2. 2.2 Ophthalmic Corticosteroid Industry Drivers
  3. 2.3 Ophthalmic Corticosteroid Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Corticosteroid Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Ophthalmic Corticosteroid Revenue by Company (2021-2026)
  2. 3.2 Global Ophthalmic Corticosteroid Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Ophthalmic Corticosteroid Key Company Head office and Area Served
  4. 3.4 Global Ophthalmic Corticosteroid Company, Product Type & Application
  5. 3.5 Global Ophthalmic Corticosteroid Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Ophthalmic Corticosteroid Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Ophthalmic Corticosteroid Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Ophthalmic Corticosteroid Tier 1, Tier 2, and Tier 3
4 Ophthalmic Corticosteroid Market by Type
  1. 4.1 Global Ophthalmic Corticosteroid Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Ophthalmic Corticosteroid Market Size by Type (2021-2032)
  3. 4.3 Global Ophthalmic Corticosteroid Market Size Share by Type (2021-2032)
5 Ophthalmic Corticosteroid Market by Application
  1. 5.1 Global Ophthalmic Corticosteroid Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Ophthalmic Corticosteroid Market Size by Application (2021-2032)
  3. 5.3 Global Ophthalmic Corticosteroid Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis AG Ophthalmic Corticosteroid Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer Ophthalmic Corticosteroid Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GlaxoSmithKline Ophthalmic Corticosteroid Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bayer AG Ophthalmic Corticosteroid Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 Sun Pharmaceutical
  26. 6.5.1 Sun Pharmaceutical Company Information
  27. 6.5.2 Sun Pharmaceutical Business Overview
  28. 6.5.3 Sun Pharmaceutical Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sun Pharmaceutical Ophthalmic Corticosteroid Product Portfolio
  30. 6.5.5 Sun Pharmaceutical Recent Developments
  31. 6.6 Regeneron Pharmaceuticals
  32. 6.6.1 Regeneron Pharmaceuticals Company Information
  33. 6.6.2 Regeneron Pharmaceuticals Business Overview
  34. 6.6.3 Regeneron Pharmaceuticals Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Regeneron Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio
  36. 6.6.5 Regeneron Pharmaceuticals Recent Developments
  37. 6.7 Orchidia
  38. 6.7.1 Orchidia Company Information
  39. 6.7.2 Orchidia Business Overview
  40. 6.7.3 Orchidia Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Orchidia Ophthalmic Corticosteroid Product Portfolio
  42. 6.7.5 Orchidia Recent Developments
  43. 6.8 Innovative Pharmaceuticals
  44. 6.8.1 Innovative Pharmaceuticals Company Information
  45. 6.8.2 Innovative Pharmaceuticals Business Overview
  46. 6.8.3 Innovative Pharmaceuticals Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Innovative Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio
  48. 6.8.5 Innovative Pharmaceuticals Recent Developments
  49. 6.9 General Pharmaceuticals
  50. 6.9.1 General Pharmaceuticals Company Information
  51. 6.9.2 General Pharmaceuticals Business Overview
  52. 6.9.3 General Pharmaceuticals Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 General Pharmaceuticals Ophthalmic Corticosteroid Product Portfolio
  54. 6.9.5 General Pharmaceuticals Recent Developments
  55. 6.10 Genentech
  56. 6.10.1 Genentech Company Information
  57. 6.10.2 Genentech Business Overview
  58. 6.10.3 Genentech Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Genentech Ophthalmic Corticosteroid Product Portfolio
  60. 6.10.5 Genentech Recent Developments
  61. 6.11 Bausch Health
  62. 6.11.1 Bausch Health Company Information
  63. 6.11.2 Bausch Health Business Overview
  64. 6.11.3 Bausch Health Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Bausch Health Ophthalmic Corticosteroid Product Portfolio
  66. 6.11.5 Bausch Health Recent Developments
  67. 6.12 Bausch and Lomb
  68. 6.12.1 Bausch and Lomb Company Information
  69. 6.12.2 Bausch and Lomb Business Overview
  70. 6.12.3 Bausch and Lomb Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bausch and Lomb Ophthalmic Corticosteroid Product Portfolio
  72. 6.12.5 Bausch and Lomb Recent Developments
  73. 6.13 Allergan
  74. 6.13.1 Allergan Company Information
  75. 6.13.2 Allergan Business Overview
  76. 6.13.3 Allergan Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Allergan Ophthalmic Corticosteroid Product Portfolio
  78. 6.13.5 Allergan Recent Developments
  79. 6.14 Alimera Sciences
  80. 6.14.1 Alimera Sciences Company Information
  81. 6.14.2 Alimera Sciences Business Overview
  82. 6.14.3 Alimera Sciences Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Alimera Sciences Ophthalmic Corticosteroid Product Portfolio
  84. 6.14.5 Alimera Sciences Recent Developments
  85. 6.15 Ajanta Pharma
  86. 6.15.1 Ajanta Pharma Company Information
  87. 6.15.2 Ajanta Pharma Business Overview
  88. 6.15.3 Ajanta Pharma Ophthalmic Corticosteroid Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Ajanta Pharma Ophthalmic Corticosteroid Product Portfolio
  90. 6.15.5 Ajanta Pharma Recent Developments
7 North America
  1. 7.1 North America Ophthalmic Corticosteroid Market Size (2021-2032)
  2. 7.2 North America Ophthalmic Corticosteroid Market Size by Type
  3. 7.2.1 North America Ophthalmic Corticosteroid Market Size by Type (2021-2026)
  4. 7.2.2 North America Ophthalmic Corticosteroid Market Size by Type (2027-2032)
  5. 7.2.3 North America Ophthalmic Corticosteroid Market Share by Type (2021-2032)
  6. 7.3 North America Ophthalmic Corticosteroid Market Size by Application
  7. 7.3.1 North America Ophthalmic Corticosteroid Market Size by Application (2021-2026)
  8. 7.3.2 North America Ophthalmic Corticosteroid Market Size by Application (2027-2032)
  9. 7.3.3 North America Ophthalmic Corticosteroid Market Share by Application (2021-2032)
  10. 7.4 North America Ophthalmic Corticosteroid Market Size by Country
  11. 7.4.1 North America Ophthalmic Corticosteroid Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Ophthalmic Corticosteroid Market Size by Country (2021-2026)
  13. 7.4.3 North America Ophthalmic Corticosteroid Market Size by Country (2027-2032)
  14. 7.4.4 North America Ophthalmic Corticosteroid Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Ophthalmic Corticosteroid Market Size (2021-2032)
  2. 8.2 Europe Ophthalmic Corticosteroid Market Size by Type
  3. 8.2.1 Europe Ophthalmic Corticosteroid Market Size by Type (2021-2026)
  4. 8.2.2 Europe Ophthalmic Corticosteroid Market Size by Type (2027-2032)
  5. 8.2.3 Europe Ophthalmic Corticosteroid Market Share by Type (2021-2032)
  6. 8.3 Europe Ophthalmic Corticosteroid Market Size by Application
  7. 8.3.1 Europe Ophthalmic Corticosteroid Market Size by Application (2021-2026)
  8. 8.3.2 Europe Ophthalmic Corticosteroid Market Size by Application (2027-2032)
  9. 8.3.3 Europe Ophthalmic Corticosteroid Market Share by Application (2021-2032)
  10. 8.4 Europe Ophthalmic Corticosteroid Market Size by Country
  11. 8.4.1 Europe Ophthalmic Corticosteroid Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Ophthalmic Corticosteroid Market Size by Country (2021-2026)
  13. 8.4.3 Europe Ophthalmic Corticosteroid Market Size by Country (2027-2032)
  14. 8.4.4 Europe Ophthalmic Corticosteroid Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Ophthalmic Corticosteroid Market Size (2021-2032)
  2. 9.2 China Ophthalmic Corticosteroid Market Size by Type
  3. 9.2.1 China Ophthalmic Corticosteroid Market Size by Type (2021-2026)
  4. 9.2.2 China Ophthalmic Corticosteroid Market Size by Type (2027-2032)
  5. 9.2.3 China Ophthalmic Corticosteroid Market Share by Type (2021-2032)
  6. 9.3 China Ophthalmic Corticosteroid Market Size by Application
  7. 9.3.1 China Ophthalmic Corticosteroid Market Size by Application (2021-2026)
  8. 9.3.2 China Ophthalmic Corticosteroid Market Size by Application (2027-2032)
  9. 9.3.3 China Ophthalmic Corticosteroid Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Ophthalmic Corticosteroid Market Size (2021-2032)
  2. 10.2 Asia Ophthalmic Corticosteroid Market Size by Type
  3. 10.2.1 Asia Ophthalmic Corticosteroid Market Size by Type (2021-2026)
  4. 10.2.2 Asia Ophthalmic Corticosteroid Market Size by Type (2027-2032)
  5. 10.2.3 Asia Ophthalmic Corticosteroid Market Share by Type (2021-2032)
  6. 10.3 Asia Ophthalmic Corticosteroid Market Size by Application
  7. 10.3.1 Asia Ophthalmic Corticosteroid Market Size by Application (2021-2026)
  8. 10.3.2 Asia Ophthalmic Corticosteroid Market Size by Application (2027-2032)
  9. 10.3.3 Asia Ophthalmic Corticosteroid Market Share by Application (2021-2032)
  10. 10.4 Asia Ophthalmic Corticosteroid Market Size by Country
  11. 10.4.1 Asia Ophthalmic Corticosteroid Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Ophthalmic Corticosteroid Market Size by Country (2021-2026)
  13. 10.4.3 Asia Ophthalmic Corticosteroid Market Size by Country (2027-2032)
  14. 10.4.4 Asia Ophthalmic Corticosteroid Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Ophthalmic Corticosteroid Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Ophthalmic Corticosteroid Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Ophthalmic Corticosteroid Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Ophthalmic Corticosteroid Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst